Burning Rock Biotech Ltd SEC filings BNR

Burning Rock Biotech Ltd has 169 filings in SEC EDGAR's recent list, going back to Nov 4, 2019. Its latest annual report, Form 20-F, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 10, 2026.

Burning Rock Biotech Ltd SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Sep 10, 2026 Sep 10, 2026
6-K Current report (foreign issuer) Jun 9, 2026 Jun 9, 2026
6-K Current report (foreign issuer) Mar 13, 2026 Mar 12, 2026
6-K Current report (foreign issuer) Dec 23, 2025 Dec 23, 2025
6-K Current report (foreign issuer) Dec 1, 2025 Dec 1, 2025
6-K Current report (foreign issuer) Nov 20, 2025 Nov 20, 2025
6-K Current report (foreign issuer) Sep 8, 2025 Sep 8, 2025
6-K Current report (foreign issuer) Jun 6, 2025 Jun 6, 2025
6-K Current report (foreign issuer) Mar 25, 2025 Mar 25, 2025
6-K Current report (foreign issuer) Dec 31, 2024 Dec 31, 2024
6-K Current report (foreign issuer) Dec 4, 2024 Dec 4, 2024
6-K Current report (foreign issuer) Dec 3, 2024 Dec 3, 2024
6-K Current report (foreign issuer) Sep 27, 2024 Sep 27, 2024
6-K Current report (foreign issuer) Sep 20, 2024 Sep 20, 2024
6-K Current report (foreign issuer) Sep 6, 2024 Sep 6, 2024
6-K Current report (foreign issuer) Aug 23, 2024 Aug 23, 2024
6-K Current report (foreign issuer) Aug 19, 2024 Aug 19, 2024
6-K Current report (foreign issuer) Jun 3, 2024 Jun 3, 2024
6-K Current report (foreign issuer) May 29, 2024 May 29, 2024
6-K Current report (foreign issuer) May 14, 2024 May 14, 2024
6-K Current report (foreign issuer) Apr 26, 2024 Apr 26, 2024
6-K Current report (foreign issuer) Mar 28, 2024 Mar 28, 2024
6-K Current report (foreign issuer) Jan 4, 2024 Jan 4, 2024
6-K Current report (foreign issuer) Dec 20, 2023 Dec 20, 2023
6-K Current report (foreign issuer) Nov 30, 2023 Nov 30, 2023
6-K Current report (foreign issuer) Nov 22, 2023 Nov 22, 2023
6-K Current report (foreign issuer) Sep 5, 2023 Aug 31, 2023
6-K Current report (foreign issuer) Jun 28, 2023 Jun 28, 2023
6-K Current report (foreign issuer) May 30, 2023 May 30, 2023
6-K Current report (foreign issuer) Apr 20, 2023 Apr 20, 2023
6-K Current report (foreign issuer) Mar 28, 2023 Mar 28, 2023
6-K Current report (foreign issuer) Jan 18, 2023 Jan 18, 2023
6-K Current report (foreign issuer) Jan 4, 2023 Jan 4, 2023
6-K Current report (foreign issuer) Nov 16, 2022 Nov 16, 2022
6-K Current report (foreign issuer) Nov 7, 2022 Nov 7, 2022
6-K Current report (foreign issuer) Nov 7, 2022 Nov 7, 2022
6-K Current report (foreign issuer) Nov 7, 2022 Jun 30, 2022
6-K Current report (foreign issuer) Nov 2, 2022 Nov 2, 2022
6-K Current report (foreign issuer) Oct 27, 2022 Oct 27, 2022
6-K Current report (foreign issuer) Oct 21, 2022 Oct 21, 2022
6-K Current report (foreign issuer) Sep 8, 2022 Sep 8, 2022
6-K Current report (foreign issuer) Aug 31, 2022 Aug 31, 2022
6-K Current report (foreign issuer) Aug 3, 2022 Aug 3, 2022
6-K Current report (foreign issuer) Jul 15, 2022 Jul 15, 2022
6-K Current report (foreign issuer) Jun 24, 2022 Jun 24, 2022
6-K Current report (foreign issuer) Jun 21, 2022 Jun 21, 2022
6-K Current report (foreign issuer) Jun 21, 2022 Jun 21, 2022
6-K Current report (foreign issuer) May 31, 2022 May 31, 2022
6-K Current report (foreign issuer) Mar 22, 2022 Mar 22, 2022
6-K Current report (foreign issuer) Dec 29, 2021 Dec 29, 2021
6-K Current report (foreign issuer) Nov 16, 2021 Nov 16, 2021
6-K Current report (foreign issuer) Aug 31, 2021 Aug 31, 2021
6-K Current report (foreign issuer) May 25, 2021 May 25, 2021
6-K Current report (foreign issuer) Mar 11, 2021 Mar 11, 2021
6-K Current report (foreign issuer) Dec 2, 2020 Dec 2, 2020
6-K Current report (foreign issuer) Nov 20, 2020 Nov 20, 2020
6-K Current report (foreign issuer) Aug 11, 2020 Aug 11, 2020

Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
BNR (Nasdaq)
Headquarters
Guangzhou, Guangdong
SEC filer status
Non-accelerated filer
SEC CIK
1792267

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.